KineMed's Debt Round

KineMed raised a round of funding on July 24, 2007. Investors include Stanford Group.

KineMed employs both pathway-based drug discovery and translational medicine-enabled drug development. KineMed's pathway-based discovery is based upon its ability to identify drugs with therapeutic ef…

Articles about KineMed's Debt Round: